Vietnam's growing capabilities in genomics, biotechnology, precision medicine and pharmaceutical research are creating a rapidly developing market for bioinformatics—the technology that turns increasingly vast quantities of biological data into meaningful scientific and clinical information.
Vietnam-specific research from Insights10 valued the country's Bioinformatics Market at US$76.75 million in 2022. While its publicly accessible report does not disclose the full 2030 forecast, applying current international bioinformatics growth rates to Vietnam's published base suggests the market could reach approximately US$210–240 million by 2030.
This would represent indicative annual growth of approximately 14–16%, although the forecast should be regarded as an estimate rather than a published Vietnam-specific projection.
Bioinformatics combines biology, computer science, statistics and data analytics to organise and interpret complex biological information.
The market encompasses technologies and services including:
- Genomic and DNA sequence analysis
- Next-generation sequencing data analysis
- Proteomics and transcriptomics
- Metabolomics
- Drug discovery informatics
- Biomarker discovery
- Clinical genomic interpretation
- Biological databases
- Sequence alignment and annotation
- Cloud-based bioinformatics
- AI and machine-learning platforms
- Data visualisation
- Bioinformatics consulting and analytical services
Genomics creates an explosion of biological data
One of the strongest drivers of bioinformatics is the rapid expansion of genomic sequencing.
Next-generation sequencing technologies can generate enormous quantities of DNA and RNA data. Producing the sequence, however, is only the first stage.
Bioinformatics is required to process raw sequencing data, align sequences, identify genetic variants and ultimately determine whether those variants have biological or clinical significance.
Vietnam's developing genomic-analysis market already includes dedicated categories for bioinformatics suites, NGS platforms, targeted gene panels, data interpretation and gene-expression analysis, demonstrating the increasingly close relationship between sequencing and computational biology.
Precision medicine increases demand for interpretation
This becomes particularly important as Vietnam develops capabilities in precision medicine.
Two patients with apparently similar diseases may have very different underlying genetic characteristics. Analysing genomic information can potentially help clinicians identify these differences and select treatments more appropriately.
Cancer represents one of the clearest examples.
Tumour sequencing can generate thousands of genomic variants. Bioinformatics platforms help filter this information to identify mutations that may be clinically significant or associated with targeted therapies.
The same infrastructure can support rare-disease diagnosis, inherited disorders, reproductive health, pharmacogenomics and personalised medicine.
Vietnam-specific DNA-sequencing research identifies increasing demand for personalised medicine and precision healthcare, growing healthcare R&D and technological advances in sequencing as important market drivers.
AI is transforming bioinformatics
Artificial intelligence represents another major growth opportunity.
Traditional bioinformatics relies heavily on algorithms and statistical analysis. Increasingly, machine learning and deep learning are being applied to much larger and more complex biological datasets.
Vietnam already has a dedicated AI in Bioinformatics Market, covering software and services across medical, animal, plant, environmental and forensic biotechnology. 6Wresearch identifies increased use of AI in drug discovery and development, government support and growing interest in personalised medicine as important drivers.
AI can potentially help researchers identify patterns across millions of genomic variants, proteins or biological interactions that would be extremely difficult to detect manually.
Drug discovery becomes increasingly computational
Bioinformatics is also changing pharmaceutical R&D.
Drug discovery traditionally involves lengthy laboratory processes to identify potential therapeutic targets and evaluate candidate molecules.
Computational biology allows researchers to use genomic, proteomic and molecular information to identify disease targets, model biological pathways and prioritise potential drug candidates before moving into laboratory and clinical testing.
The latest global bioinformatics research identifies clinical development of biopharmaceuticals and three-dimensional drug design among important drivers of market growth.
For Vietnam, this connects bioinformatics directly with the country's ambitions to develop a higher-value pharmaceutical and biotechnology industry.
IMARC Group values the wider Vietnam Biotechnology Market at US$3.41 billion in 2025, forecasting it to reach US$8.86 billion by 2034, at a 10.87% CAGR. Bioinformatics is specifically included as one of the market's application categories.
Multi-omics expands the opportunity
The next phase of bioinformatics goes beyond DNA.
Modern life-sciences research increasingly combines multiple layers of biological information:
Genomics examines DNA.
Transcriptomics examines RNA and gene expression.
Proteomics examines proteins.
Metabolomics examines metabolites and biochemical activity.
Integrating these different datasets—often described as multi-omics—can provide a much more detailed understanding of disease biology.
But it also creates exponentially greater quantities of data.
Bioinformatics therefore becomes the computational infrastructure connecting genomics, proteomics, transcriptomics and metabolomics into an integrated picture of human biology.
Cloud computing changes access to bioinformatics
Bioinformatics traditionally required substantial local computing infrastructure because genomic datasets can be extremely large.
Cloud computing is changing that model.
Research institutions, hospitals, pharmaceutical companies and biotechnology businesses can increasingly access computational resources as required rather than building their own high-performance computing environments.
The latest Vietnam Genomic Analysis research specifically identifies SaaS delivery alongside direct sales, laboratory suppliers and OEM partnerships as a distribution model for genomic and bioinformatics technologies.
This could lower barriers to adoption for Vietnamese research organisations and laboratories while creating opportunities for specialist software and cloud-service providers.
Global bioinformatics market heads towards US$64 billion
The international growth trajectory demonstrates the scale of the transformation.
Grand View Research values the global Bioinformatics Market at US$20.1 billion in 2025, increasing to US$23.5 billion in 2026 and US$63.7 billion by 2033, representing a 15.3% CAGR from 2026–2033.
The latest August 2026 research from 360iResearch provides a similar outlook, estimating US$18.24 billion in 2025, US$20.69 billion in 2026 and US$44.73 billion by 2032, at a 13.66% CAGR.
Bioinformatics services are growing even faster. Research and Markets values the global Bioinformatics Services Market at US$6.1 billion in 2025 and forecasts a 17.3% CAGR through 2034, driven by genomics, proteomics, personalised medicine and drug discovery.
Vietnam's opportunity extends across life sciences
For Vietnam, the commercial opportunity extends considerably beyond standalone bioinformatics software.
The ecosystem encompasses NGS, genomic sequencing, cloud computing, AI, laboratory informatics, biological databases, data analytics, clinical interpretation, cybersecurity and specialist analytical services.
Potential users include pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, universities, research institutions, CROs and genomic research centres.
Vietnam's dedicated Life Sciences IT research already identifies bioinformatics alongside drug-discovery informatics, clinical-trial management and laboratory information management as one of the country's core life-sciences technology categories.
As Vietnam generates increasing quantities of genomic and other biological data, the ability to store, analyse, interpret and translate that information into scientific and clinical insight will become increasingly valuable.
With a published market base of US$76.75 million in 2022 and global bioinformatics markets currently expanding at around 14–15% annually, Vietnam could develop into a US$200 million-plus bioinformatics market by the end of the decade.